Remove 2012 Remove Asset Management Remove Globalization Remove Marketing
article thumbnail

Japan Is Counting on Shareholder Activism to Improve Its Economy

Harvard Business Review

Abe has even met with one of the most prominent American activists, Dan Loeb , in a private albeit well-publicized encounter, suggesting he sees value in foreign involvement in Japanese markets. They seek to win management over by sharing well-researched analysis and connecting them to a network of potential partners.

ROE 8
article thumbnail

Spain Is Now Making Ireland's Mistakes

Harvard Business Review

The Spanish Prime Minister has become preoccupied with creating market confidence, as was the Irish Prime Minister in the run up to the EU/IMF bailout. By March 2012 unemployment was 24.1 percent and youth unemployment reached 29 percent in early 2012. The accent heard today in Madrid has a distinct Irish lilt to it.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The End of Economists' Imperialism

Harvard Business Review

"By almost any market test, economics is the premier social science," Stanford University economist Edward Lazear wrote just over a decade ago. The field attracts the most students, enjoys the attention of policy-makers and journalists, and gains notice, both positive and negative, from other scientists.".

Tversky 11
article thumbnail

Top 10 Green Business Stories of 2011

Harvard Business Review

The ongoing failure of policy at a global level (with the important exceptions of some successes/workarounds such as new mileage targets for cars and trucks and a carbon tax in Australia ). The best analysis of the resource scarcity mega-trend came from asset manager Jeremy Grantham. Right now, the U.S. Nuclear on the outs.

article thumbnail

Innovation Is as Much About Finding Partners as Building Products

Harvard Business Review

DNA genetic testing company 23andMe fell behind on its communications with the FDA, resulting in a temporary ban on marketing the company’s personal genetic screening services to the public. The inadequacies of the old approach are evident in recent startup stumbles, even when the technology is sound.